Surgisis Gold Graft
DeviceSurgisis Gold Graft is placed as an underlay following open bariatric surgery.
NCT Number: NCT00274625
The primary objective is to compare the effectiveness of the Surgisis Gold Graft to suture closure alone in preventing an incisional hernia after open bariatric surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Mayo Clinic Foundation, Rochester, Minnesota, United States
This will be a prospective, randomized clinical trial comparing outcomes of use of a sublay of Surgisis Gold Graft for tissue reinforcement, as compared to suture closure alone in evaluating incidence of incisional hernias. Prior to undergoing open bariatric surgery, patients will be randomized to receive either Surgisis Gold Graft or suture closure alone. Subjects will be seen for follow-up visits at six weeks, three months, six months, one year and two years post-operatively. Patients may see their primary care physician for the one and two follow-up visits.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgisis Gold Graft is placed as an underlay following open bariatric surgery.
Incision is closed without the placement of a graft material (standard of care control)
Time frame: 2 years
An obvious defect or interruption of the fascia in the area of the incision that was palpable on clinical examination and/or visible by a cross-sectional imaging modality.
Cook Group Incorporated
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07360691
Abdominal Wall Hernia, Hernia
Mandya, Karnataka, India
View Trial DetailsNCT07316426
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, HERNIA, VENTRAL
Gällivare, Norrbotten County, Sweden
View Trial DetailsNCT07220382
Botox Injection, Hernia
Cleveland, Ohio, United States
View Trial DetailsNCT05142618
Abdominal Wall, Hernia
Columbus, Ohio, United States
View Trial Details